Gerald Grutz
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
ILOBONE: A phase I/IIa randomized controlled trial to assess the safety and feasibility of local iloprost therapy for enhancing proximal humerus fracture healing- a pilot study design.
Journal: Journal of orthopaedic surgery and research
Published: February 18, 2025
Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis.
Journal: Neurology and therapy
Published: May 15, 2024
Individual immune cell and cytokine profiles determine platelet-rich plasma composition.
Journal: Arthritis research & therapy
Published: May 03, 2022
Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD.
Journal: Journal of neuroinflammation
Published: April 08, 2022
Generation of HBsAg-reactive T- and B-cells following HBV vaccination in serological non-responders under hemodialysis treatment.
Journal: European journal of immunology
Published: May 25, 2020
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial.
Journal: International journal of cancer
Published: December 17, 2018
Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4+ memory T cells.
Journal: Nature communications
Published: September 17, 2018
Gravitational stress during parabolic flights reduces the number of circulating innate and adaptive leukocyte subsets in human blood.
Journal: PloS one
Published: May 30, 2018
TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 production.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 10, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026